Hong Kong-listed Chinese drug firms set to turn corner on rising sales, licensing deals
Hong Kong-listed Chinese pharmaceutical companies are expected to experience profit growth driven by increased sales of innovative drugs and favorable licensing agreements despite existing pricing challenges.
Trump hands to-do list to Congress with 7 priorities during State of the Union address
During his State of the Union address, President Trump presented Congress with seven legislative priorities, focusing on drug pricing, border security, and crime policy.
Increase in Medication Reimbursements Paid by Kela
Reimbursements for medications by Kela rose by 4% to a total of 1.98 billion euros in 2025, driven by more patients using new and expensive medications.
Novo Nordisk will halve the price of its anti-obesity drug Wegovy in the United States starting in 2027
Novo Nordisk announced a plan to reduce the price of its anti-obesity drug Wegovy by 50% in the U.S. starting in 2027 to improve affordability and competitiveness.
I need an expensive asthma drug to live. Trump’s RX plan helped me and many others
A personal account highlights how President Trump's RX plan is providing crucial financial relief for those with chronic illnesses like asthma.
The Dangers of Drug Price Cuts Based on Fiscal Logic
The South Korean government's policy to reduce drug prices raises concerns about its potential negative impact on public health and the domestic pharmaceutical industry's sustainability.
AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment
AstraZeneca's CEO recognizes a new NHS drug pricing deal as a positive move, yet it will not lead to the resumption of a £200m investment in the UK.
The First Year of Drug Reform: 90% of Prescription Drugs Have Become Cheaper, Non-Prescription Prices Continue to Rise
Latvia's drug pricing reform has led to a significant decrease in prescription drug prices, while non-prescription drugs are seeing continued price increases.
UK, US drug pricing deal to cost £1bn over three years
A new UK-US pharmaceutical agreement will result in the National Health Service incurring costs of £1 billion over the next three years due to increased medicine prices and tariff exemptions.
Idec criticizes new drug pricing rules and says medicines could become more expensive
Idec expresses concerns that Brazil's new drug pricing regulations, effective from April, may not address fundamental issues in pricing policy and could further restrict access to medications.
Trump slips into French accent while recounting blunt phone call with Macron
President Donald Trump humorously adopted a French accent while discussing a phone call with French President Emmanuel Macron about drug pricing during a White House rural healthcare roundtable.